Multicentre Isradipine Dose-Confirmation Study in Thai Patients With Hypertension
Isradipine is a new calcium antagonist of the dihydropyridine type, with marked vasodilator activity and minimum negative inotropic effects. It is a potent antihypertensive drug when given as monotherapy. This was a single-blind multicentre study consisting of 2 weeks’ placebo pretreatment and 8 wee...
Saved in:
Main Authors: | Supachai Tanoup, Prapatra Tantbirojn, Banharn Koanantakul, Sawate Nontakanun, Nibha Jaroonvesama, Kawi Charoenlarp |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/16164 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Clinical trial on indapamide in the treatment of hypertension
by: K. Charoenlarp, et al.
Published: (2018) -
Differential diagnosis of eosinophilic meningitis
by: Nibha Jaroonvesama
Published: (2018) -
The efficacy and tolerability of barnidipine hydrochloride in Thai patients with hypertension
by: Peera Buranakitjaroen, et al.
Published: (2018) -
Preeclampsia: Haemostatic status and the short-term effects of methyldopa and isradipine therapy
by: Yin, K.H., et al.
Published: (2013) -
Randomised controlled trial of methyldopa and isradipine in preeclampsia - Effects on uteroplacental and fetal hemodynamics
by: Montan, S., et al.
Published: (2013)